![Nai De Si](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nai De Si
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Nai De Si
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Nantong University
2
| College/University | Other Consumer Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nai De Si
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Takara Bio USA, Inc.
![]() Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Hongwei Technologies Ltd.
![]() Hongwei Technologies Ltd. TextilesProcess Industries Hongwei Technologies Ltd. engages in the manufacture and sale of polyester differential fibers primarily to yarn and textile manufacturers located in the southern parts of China. It also provides customized services to its customers such as product testing, elasticity tuning and thickness fitting. The company was founded by Zhuang Xin Xin and Lin Ji Miao on March 3, 2005 and is headquartered in Xiamen, China. | Textiles | Director/Board Member | |
Nagoya University | College/University | Doctorate Degree | |
The Memorial Foundation, Inc. | Corporate Officer/Principal | ||
Biomics Biotechnologies Co., Ltd.
![]() Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Biotechnology | Chief Executive Officer | |
Zytogene, Inc. | Chief Tech/Sci/R&D Officer | ||
NT Omics, Inc. | Founder | ||
China Pharmaceutical University | College/University | Corporate Officer/Principal | |
BIOMICS BIOPHARMA LTD | Chemicals: Specialty | Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 5 |
China | 5 |
Vereinigtes Königreich | 2 |
Japan | 2 |
Sektoral
Health Technology | 3 |
Process Industries | 3 |
Consumer Services | 3 |
Health Services | 2 |
Operativ
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Chief Executive Officer | 2 |
Chairman | 2 |
Founder | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Yuan Yuan Zhu | 10 |
Chao Dong Xing | 2 |